Location History:
- Belmont, CA (US) (2013)
- San Francisco, CA (US) (2009 - 2018)
Company Filing History:
2 out of 3,223 
1 out of 15,513 
1 out of 98 
Years Active: 2009-2018
Title: Hua Tian: Innovator in Notch Pathway Inhibition and Tumor Diagnosis
Introduction
Hua Tian is a prominent inventor based in San Francisco, CA, known for her significant contributions to the fields of cancer research and cellular signaling. With a total of 3 patents, she has made strides in developing innovative methods for diagnosing tumors and inhibiting the Notch signaling pathway.
Latest Patents
One of her latest patents focuses on Notch pathway inhibition, providing a method that reduces toxicity while effectively targeting this critical signaling pathway. Another notable invention is a method for diagnosing the presence of a tumor in mammals by assessing CDO expression levels. This invention utilizes BOC/CDO hedgehog antagonists to inhibit hedgehog signaling, which is crucial for treating and diagnosing various disorders, including cancer and other conditions influenced by hedgehog signaling.
Career Highlights
Hua Tian has worked with renowned organizations such as Genentech, Inc. and the University of California. Her work has significantly impacted the understanding and treatment of disorders related to hedgehog signaling, showcasing her dedication to advancing medical science.
Collaborations
Throughout her career, Hua has collaborated with esteemed colleagues, including Frederic J De Sauvage and Fred De Sauvage, further enhancing her research and innovation efforts.
Conclusion
Hua Tian's contributions to the fields of cancer research and cellular signaling through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical diagnostics and treatment options.